Total Payments
$3,603
2024 Payments
$1,717
Companies
30
Transactions
42
Medicare Patients
935
Medicare Billing
$73,127
Payment Breakdown by Category
Food & Beverage$3,339 (92.7%)
Education$264.05 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,339 | 39 | 92.7% |
| Education | $264.05 | 3 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $349.93 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $302.64 | 6 | $0 (2024) |
| GENZYME CORPORATION | $199.08 | 2 | $0 (2022) |
| Dexcom, Inc. | $154.25 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $129.10 | 1 | $0 (2022) |
| Abbott Laboratories | $127.60 | 1 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $127.05 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $124.99 | 1 | $0 (2024) |
| ABBVIE INC. | $123.82 | 1 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $123.27 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,717 | 20 | Janssen Biotech, Inc. ($254.74) |
| 2023 | $574.93 | 7 | Sumitomo Pharma America, Inc. ($127.05) |
| 2022 | $817.91 | 10 | AstraZeneca Pharmaceuticals LP ($129.10) |
| 2021 | $492.87 | 5 | GENZYME CORPORATION ($125.41) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Food and Beverage | In-kind items and services | $80.31 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $115.06 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $90.00 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: Oncology | ||||||
| 11/01/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $154.25 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 09/16/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $89.84 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $85.05 | General |
| 08/21/2024 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Central Nervous System | ||||||
| 08/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $101.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/23/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $113.03 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/31/2024 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $89.00 | General |
| Category: ONCOLOGY | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $123.82 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $95.43 | General |
| Category: Obesity | ||||||
| 11/14/2023 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $98.22 | General |
| Category: Sleep Apnea testing | ||||||
| 09/28/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: Urology | ||||||
| 06/21/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/15/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $100.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 264 | 377 | $85,976 | $21,664 |
| 2022 | 5 | 258 | 302 | $72,301 | $17,382 |
| 2021 | 7 | 268 | 300 | $56,868 | $13,495 |
| 2020 | 3 | 145 | 292 | $68,748 | $20,586 |
Total Patients
935
Total Services
1,271
Medicare Billing
$73,127
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 181 | 235 | $55,705 | $13,959 | 25.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 67 | $10,720 | $3,536 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 27 | $8,559 | $2,474 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 16 | 16 | $5,776 | $1,157 | 20.0% |
| 51701 | Insertion of temporary bladder tube | Facility | 2023 | 29 | 32 | $5,216 | $538.12 | 10.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 172 | 213 | $50,895 | $12,732 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 26 | 26 | $9,536 | $1,987 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 28 | 31 | $4,960 | $1,318 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 11 | $3,487 | $997.88 | 28.6% |
| 51701 | Insertion of temporary bladder tube | Facility | 2022 | 21 | 21 | $3,423 | $346.71 | 10.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 97 | 107 | $17,408 | $4,872 | 28.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 68 | 74 | $17,510 | $4,768 | 27.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 36 | 43 | $4,085 | $1,066 | 26.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 19 | 19 | $4,642 | $988.38 | 21.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $3,971 | $980.44 | 24.7% |
| 51701 | Insertion of temporary bladder catheter | Facility | 2021 | 25 | 26 | $4,715 | $468.00 | 9.9% |
| 51702 | Insertion of indwelling bladder catheter, simple | Facility | 2021 | 12 | 20 | $4,537 | $352.60 | 7.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 87 | 230 | $53,130 | $15,901 | 29.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 44 | 48 | $11,376 | $3,418 | 30.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $4,242 | $1,267 | 29.9% |
About Melissa Voltz, NP
Melissa Voltz, NP is a Family healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1598053563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Voltz, NP has received a total of $3,603 in payments from pharmaceutical and medical device companies, with $1,717 received in 2024. These payments were reported across 42 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,339).
As a Medicare-enrolled provider, Voltz has provided services to 935 Medicare beneficiaries, totaling 1,271 services with total Medicare billing of $73,127. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location New Orleans, LA
- Active Since 07/12/2011
- Last Updated 07/12/2011
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1598053563
Products in Payments
- XTANDI (Drug) $349.93
- ERLEADA (Drug) $254.74
- DEXCOM G7 GSS (161) (Medical Supply) $154.25
- TEZSPIRE (Biological) $129.10
- FREESTYLE LIBRE 2 (Device) $127.60
- GEMTESA (Drug) $127.05
- FABRAZYME (Biological) $125.41
- Austedo XR (Drug) $124.99
- VRAYLAR (Drug) $123.82
- IMBRUVICA (Drug) $123.27
- DUPIXENT (Biological) $121.83
- CABOMETYX (Drug) $121.82
- DOVATO (Drug) $121.49
- SPRAVATO (Drug) $115.06
- KRYSTEXXA (Biological) $113.63
- INTERSTIM (Device) $113.03
- STRENSIQ (Biological) $108.66
- VOQUEZNA (Drug) $101.66
- LifeVest (Device) $100.00
- Epclusa (Drug) $99.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in New Orleans
Erin Pierce, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $170,792
Family $170,792
Lori Lemoine, Fnp-C, FNP-C
Family — Payments: $16,925
Family $16,925
Aimee Scroggs
Family — Payments: $9,375
Family $9,375
Robert Byram, Fnp, FNP
Family — Payments: $8,311
Family $8,311
Mrs. Elisha Collins Johnson, Aprn, Fnp, APRN, FNP
Family — Payments: $7,286
Family $7,286
Michelle Mccloskey, Fnp, FNP
Family — Payments: $7,256
Family $7,256